Publications by authors named "Lisa Borbridge"

Claim this Profile
P
Pharmacokinetics and Safety of Atogepant Co-administered with Quinidine Gluconate in Healthy Participants: A Phase 1, Open-Label, Drug-Drug Interaction Study.
Ramesh Boinpally, Lisa Borbridge, Veronica Wangsadipura

Clin Pharmacol Drug Dev· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and Safety of Coadministered Atogepant and Topiramate in Healthy Participants: A Phase 1, Open-Label, Drug-Drug Interaction Study.
Ramesh Boinpally, Danielle McGeeney, Lisa Borbridge, Joel Trugman

Clin Pharmacol Drug Dev· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the pharmacokinetic interactions and safety of atogepant coadministered with esomeprazole.
Ramesh Boinpally, Matthew Butler, Jonathan Rojo, Lisa Borbridge, Veronica Wangsadipura

Pain Manag· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Single Supratherapeutic Dose of Atogepant Does Not Affect Cardiac Repolarization in Healthy Adults: Results From a Randomized, Single-Dose, Phase 1 Crossover Trial.
Ramesh Boinpally, Brian McNamee, Li Yao, Matthew Butler, Danielle McGeeney, Lisa Borbridge

Clin Pharmacol Drug Dev· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-Dose Pharmacokinetics and Safety of Atogepant in Adults With Hepatic Impairment: Results From an Open-Label, Phase 1 Trial.
Ramesh Boinpally, Abhijeet Jakate, Matthew Butler, Lisa Borbridge, Antonia Periclou

Clin Pharmacol Drug Dev· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and safety of ubrogepant when coadministered with calcitonin gene-related peptide-targeted monoclonal antibody migraine preventives in participants with migraine: A randomized phase 1b drug-drug interaction study.
Abhijeet Jakate, Andrew M Blumenfeld, Ramesh Boinpally, Matthew Butler, Lisa Borbridge

Headache· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ocular penetration and anti-inflammatory activity of ketorolac 0.45% and bromfenac 0.09% against lipopolysaccharide-induced inflammation.
L David Waterbury, Danielle Galindo, Linda Villanueva, Cathy Nguyen, Milan Patel, Lisa Borbridge

J Ocul Pharmacol Ther· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ocular pharmacokinetics of 0.45% ketorolac tromethamine.
Mayssa Attar, Rhett Schiffman, Lisa Borbridge, Quinn Farnes, Devin Welty

Clin Ophthalmol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microdosing assessment to evaluate pharmacokinetics and drug metabolism in rats using liquid chromatography-tandem mass spectrometry.
Jinsong Ni, Hui Ouyang, Mauro Aiello, Carmai Seto, Lisa Borbridge

Pharm Res· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis